This inventor holds 36 USPTO granted patents and 3 published patent applications, plus 8 CIPO patents and 13 EPO patents, primarily in Viral Vaccine Development. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2004-2023.
Location History:
- La Gareme-Colombes, FR (2012)
- Garenne-Colombes, FR (2005 - 2014)
- Sant-Denis La Reunion, FR (2017)
- La Garenne-Colombes, FR (2004 - 2019)
- Sainte Clotilde la Reunion, FR (2020)
- La Réunion, FR (2020)
- Sant-Denis, FR (2020 - 2023)
Company Filing History:
34 out of 897 
13 out of 5,383 
3 out of 1,853 
Years Active: 2004-2023
Areas of Expertise:
Title: Innovator Spotlight: Philippe Despres - Pioneering Vaccine Technologies
Introduction:
Philippe Despres, a prolific inventor hailing from La Garenne-Colombes, France, has made significant contributions to the field of virology and vaccine development. With an impressive portfolio of 36 patents to his name, Despres is recognized for his groundbreaking work in creating novel vaccine compositions to combat infectious diseases.
Latest Patents:
Despres's recent patents showcase his ingenuity and dedication to advancing immunization strategies. One notable innovation is the lentiviral vector-based Japanese encephalitis (JE) immunogenic composition. This invention involves a recombinant lentiviral vector expressing key proteins of the Japanese encephalitis virus, offering promising methods for preventing JEV infections in mammalian hosts.
Another cutting-edge patent by Despres pertains to vaccine compositions comprising an attenuated mutant Zika virus. By strategically mutating specific amino acid residues on the E protein, Despres and his team have developed a Zika vaccine that not only mitigates cytopathic effects but also reduces the risk of autoimmune complications such as Guillain-Barre syndrome.
Career Highlights:
Throughout his career, Philippe Despres has made significant strides in virology research while collaborating with esteemed institutions such as Institut Pasteur and Centre National De La Recherche Scientifique. His innovative approach to vaccine design has garnered international recognition, positioning him as a leading figure in the fight against emerging infectious diseases.
Collaborations:
Despres's contributions have been enriched by collaborations with talented scientists like Marie-Pascale Frenkiel and Sylvie Paulous. Together, they have synergized their expertise to create impactful solutions for global health challenges, cementing Despres's reputation as a team player and visionary inventor.
Conclusion:
In conclusion, Philippe Despres stands as a trailblazing innovator in the realm of vaccine technologies, with a proven track record of developing high-impact solutions for infectious diseases. His relentless pursuit of scientific excellence and collaborative spirit continue to inspire advancements in public health and immunization strategies worldwide.